Cargando…
Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19
Mild thrombocytopenia, changes in platelet gene expression, enhanced platelet functionality, and presence of platelet-rich thrombi in the lung have been associated with thromboinflammatory complications of patients with COVID-19. However, whether severe acute respiratory syndrome coronavirus 2 (SARS...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068266/ https://www.ncbi.nlm.nih.gov/pubmed/35789374 http://dx.doi.org/10.1182/bloodadvances.2022007143 |
_version_ | 1784700189871702016 |
---|---|
author | Garcia, Cédric Au Duong, Jonathan Poëtte, Michael Ribes, Agnès Payre, Bruno Mémier, Vincent Sié, Pierre Minville, Vincent Voisin, Sophie Payrastre, Bernard Vardon-Bounes, Fanny |
author_facet | Garcia, Cédric Au Duong, Jonathan Poëtte, Michael Ribes, Agnès Payre, Bruno Mémier, Vincent Sié, Pierre Minville, Vincent Voisin, Sophie Payrastre, Bernard Vardon-Bounes, Fanny |
author_sort | Garcia, Cédric |
collection | PubMed |
description | Mild thrombocytopenia, changes in platelet gene expression, enhanced platelet functionality, and presence of platelet-rich thrombi in the lung have been associated with thromboinflammatory complications of patients with COVID-19. However, whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) gets internalized by platelets and directly alters their behavior and function in infected patients remains elusive. Here, we investigated platelet parameters and the presence of viral material in platelets from a prospective cohort of 29 patients with severe COVID-19 admitted to an intensive care unit. A combination of specific assays, tandem mass spectrometry, and flow cytometry indicated high levels of protein and lipid platelet activation markers in the plasma from patients with severe COVID-19 associated with an increase of proinflammatory cytokines and leukocyte-platelets interactions. Platelets were partly desensitized, as shown by a significant reduction of αIIbβ3 activation and granule secretion in response to stimulation and a decrease of surface GPVI, whereas plasma from patients with severe COVID-19 potentiated washed healthy platelet aggregation response. Transmission electron microscopy indicated the presence of SARS-CoV-2 particles in a significant fraction of platelets as confirmed by immunogold labeling and immunofluorescence imaging of Spike and nucleocapsid proteins. Compared with platelets from healthy donors or patients with bacterial sepsis, platelets from patients with severe COVID-19 exhibited enlarged intracellular vesicles and autophagolysosomes. They had large LC3-positive structures and increased levels of LC3II with a co-localization of LC3 and Spike, suggesting that platelets can digest SARS-CoV-2 material by xenophagy in critically ill patients. Altogether, these data show that during severe COVID-19, platelets get activated, become partly desensitized, and develop a selective autophagy response. |
format | Online Article Text |
id | pubmed-9068266 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-90682662022-05-05 Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19 Garcia, Cédric Au Duong, Jonathan Poëtte, Michael Ribes, Agnès Payre, Bruno Mémier, Vincent Sié, Pierre Minville, Vincent Voisin, Sophie Payrastre, Bernard Vardon-Bounes, Fanny Blood Adv Platelets and Thrombopoiesis Mild thrombocytopenia, changes in platelet gene expression, enhanced platelet functionality, and presence of platelet-rich thrombi in the lung have been associated with thromboinflammatory complications of patients with COVID-19. However, whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) gets internalized by platelets and directly alters their behavior and function in infected patients remains elusive. Here, we investigated platelet parameters and the presence of viral material in platelets from a prospective cohort of 29 patients with severe COVID-19 admitted to an intensive care unit. A combination of specific assays, tandem mass spectrometry, and flow cytometry indicated high levels of protein and lipid platelet activation markers in the plasma from patients with severe COVID-19 associated with an increase of proinflammatory cytokines and leukocyte-platelets interactions. Platelets were partly desensitized, as shown by a significant reduction of αIIbβ3 activation and granule secretion in response to stimulation and a decrease of surface GPVI, whereas plasma from patients with severe COVID-19 potentiated washed healthy platelet aggregation response. Transmission electron microscopy indicated the presence of SARS-CoV-2 particles in a significant fraction of platelets as confirmed by immunogold labeling and immunofluorescence imaging of Spike and nucleocapsid proteins. Compared with platelets from healthy donors or patients with bacterial sepsis, platelets from patients with severe COVID-19 exhibited enlarged intracellular vesicles and autophagolysosomes. They had large LC3-positive structures and increased levels of LC3II with a co-localization of LC3 and Spike, suggesting that platelets can digest SARS-CoV-2 material by xenophagy in critically ill patients. Altogether, these data show that during severe COVID-19, platelets get activated, become partly desensitized, and develop a selective autophagy response. American Society of Hematology 2022-07-05 /pmc/articles/PMC9068266/ /pubmed/35789374 http://dx.doi.org/10.1182/bloodadvances.2022007143 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://www.ncbi.nlm.nih.gov/pmc/pmcdoc/tagging-guidelines/article/tags.html#el-licenseThis article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | Platelets and Thrombopoiesis Garcia, Cédric Au Duong, Jonathan Poëtte, Michael Ribes, Agnès Payre, Bruno Mémier, Vincent Sié, Pierre Minville, Vincent Voisin, Sophie Payrastre, Bernard Vardon-Bounes, Fanny Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19 |
title | Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19 |
title_full | Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19 |
title_fullStr | Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19 |
title_full_unstemmed | Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19 |
title_short | Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19 |
title_sort | platelet activation and partial desensitization are associated with viral xenophagy in patients with severe covid-19 |
topic | Platelets and Thrombopoiesis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068266/ https://www.ncbi.nlm.nih.gov/pubmed/35789374 http://dx.doi.org/10.1182/bloodadvances.2022007143 |
work_keys_str_mv | AT garciacedric plateletactivationandpartialdesensitizationareassociatedwithviralxenophagyinpatientswithseverecovid19 AT auduongjonathan plateletactivationandpartialdesensitizationareassociatedwithviralxenophagyinpatientswithseverecovid19 AT poettemichael plateletactivationandpartialdesensitizationareassociatedwithviralxenophagyinpatientswithseverecovid19 AT ribesagnes plateletactivationandpartialdesensitizationareassociatedwithviralxenophagyinpatientswithseverecovid19 AT payrebruno plateletactivationandpartialdesensitizationareassociatedwithviralxenophagyinpatientswithseverecovid19 AT memiervincent plateletactivationandpartialdesensitizationareassociatedwithviralxenophagyinpatientswithseverecovid19 AT siepierre plateletactivationandpartialdesensitizationareassociatedwithviralxenophagyinpatientswithseverecovid19 AT minvillevincent plateletactivationandpartialdesensitizationareassociatedwithviralxenophagyinpatientswithseverecovid19 AT voisinsophie plateletactivationandpartialdesensitizationareassociatedwithviralxenophagyinpatientswithseverecovid19 AT payrastrebernard plateletactivationandpartialdesensitizationareassociatedwithviralxenophagyinpatientswithseverecovid19 AT vardonbounesfanny plateletactivationandpartialdesensitizationareassociatedwithviralxenophagyinpatientswithseverecovid19 |